Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

64.10p
   
  • Change Today:
      2.10p
  • 52 Week High: 121.60
  • 52 Week Low: 35.30
  • Currency: UK Pounds
  • Shares Issued: 540.00m
  • Volume: 1,042,096
  • Market Cap: £346.14m
  • RiskGrade: 119

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
76.83% below the market average76.83% below the market average76.83% below the market average76.83% below the market average76.83% below the market average
62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average
1yr Revenue Growth
50.35% below the market average50.35% below the market average50.35% below the market average50.35% below the market average50.35% below the market average
36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
25.89% below the market average25.89% below the market average25.89% below the market average25.89% below the market average25.89% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
1yr DPS Growth
28.4% below the market average28.4% below the market average28.4% below the market average28.4% below the market average28.4% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
11.37% below the market average11.37% below the market average11.37% below the market average11.37% below the market average11.37% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average
Price Book Ratio
12.93% below the market average12.93% below the market average12.93% below the market average12.93% below the market average12.93% below the market average
32.20% above the sector average32.20% above the sector average32.20% above the sector average32.20% above the sector average32.20% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
9.15% above the market average9.15% above the market average9.15% above the market average9.15% above the market average9.15% above the market average
46.03% above the sector average46.03% above the sector average46.03% above the sector average46.03% above the sector average46.03% above the sector average
Price Chg 3m
79.24% above the market average79.24% above the market average79.24% above the market average79.24% above the market average79.24% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
35.69% above the market average35.69% above the market average35.69% above the market average35.69% above the market average35.69% above the market average
36.67% above the sector average36.67% above the sector average36.67% above the sector average36.67% above the sector average36.67% above the sector average
Momentum 20
4.33% below the market average4.33% below the market average4.33% below the market average4.33% below the market average4.33% below the market average
23.33% below the sector average23.33% below the sector average23.33% below the sector average23.33% below the sector average23.33% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
6.83% below the market average6.83% below the market average6.83% below the market average6.83% below the market average6.83% below the market average
39.53% above the sector average39.53% above the sector average39.53% above the sector average39.53% above the sector average39.53% above the sector average
ROCE
14.63% above the market average14.63% above the market average14.63% above the market average14.63% above the market average14.63% above the market average
5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
7.65% above the market average7.65% above the market average7.65% above the market average7.65% above the market average7.65% above the market average
53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average
Forecast EPS
60% below the market average60% below the market average60% below the market average60% below the market average60% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
40.67% above the market average40.67% above the market average40.67% above the market average40.67% above the market average40.67% above the market average
58.14% above the sector average58.14% above the sector average58.14% above the sector average58.14% above the sector average58.14% above the sector average
Operating Profit Loss
25.93% above the market average25.93% above the market average25.93% above the market average25.93% above the market average25.93% above the market average
73.77% above the sector average73.77% above the sector average73.77% above the sector average73.77% above the sector average73.77% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
41.78% above the market average41.78% above the market average41.78% above the market average41.78% above the market average41.78% above the market average
58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average
Cash
37.36% above the market average37.36% above the market average37.36% above the market average37.36% above the market average37.36% above the market average
54.10% above the sector average54.10% above the sector average54.10% above the sector average54.10% above the sector average54.10% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
3.56% above the market average3.56% above the market average3.56% above the market average3.56% above the market average3.56% above the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Brokers Percent Neutral
2.50% above the market average2.50% above the market average2.50% above the market average2.50% above the market average2.50% above the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.10p
Change Today 2.10p
% Change 3.39 %
52 Week High 121.60
52 Week Low 35.30
Volume 1,042,096
Shares Issued 540.00m
Market Cap £346.14m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.65% above the market average17.65% above the market average17.65% above the market average17.65% above the market average17.65% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Price Trend
25.59% below the market average25.59% below the market average25.59% below the market average25.59% below the market average25.59% below the market average
20.63% above the sector average20.63% above the sector average20.63% above the sector average20.63% above the sector average20.63% above the sector average
Income
40.84% below the market average40.84% below the market average40.84% below the market average40.84% below the market average40.84% below the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average
Growth
88.53% below the market average88.53% below the market average88.53% below the market average88.53% below the market average88.53% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 24-Mar-2023

Time Volume / Share Price
17:17 7,312 @ 63.73p
16:35 162,008 @ 64.10p
16:35 1,870 @ 64.10p
16:35 912 @ 64.10p
16:35 1,037 @ 64.10p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page